ABSTRACT
Introduction
Pharyngitis is a common reason for primary care visits, and emergency departments (EDs) are often the site of care. Despite many recommendations, physician management remains inconsistent, with most physicians using clinical suspicion as a reason to prescribe antibiotics. [1] [2] [3] [4] Reliance on throat cultures is associated with difficulty in communicating test results to patients once they have left the ED. 5 The sore throat score, 6 a clinical approach to the evaluation of patients who present with sore throats, has been developed for use in community-based family practice (see Fig. 1 , page 182). The goal of this approach is to identify and treat group A streptococcal (GAS) infections in order to prevent the sequelae of these infections: rheumatic fever and peritonsilar abscess. This clinical approach has the potential to achieve a 48% reduction in antibiotic use in the family practice setting and to reduce the need for throat cultures, 6 and patients are spared the expense and side effects of unnecessary treatment. Validation of this prediction rule is required when applying it in new clinical settings such as the ED. 7 Because this approach was originally investigated in an ED for use in adults, 8 it is appealing to apply it in this setting as well. However, the sore throat score approach recommends throat culture if the patient has a total score of 2 or 3. As a result, telephone follow-up is necessary (to convey culture results and recommendation for therapy). In contrast, rapid test results are available within minutes and could eliminate the need for follow-up. The purpose of this study was first to evaluate the performance of the score approach in the ED and to examine the accuracy and impact of incorporating rapid testing. We hoped to devise a strategy to further decrease antibiotic use without missing more than an additional 10% of GAS infections, thereby eliminating the need for throat culture and the associated follow-up problems. 
Methods
Approval for this study was obtained from the ethics committees of the Etobicoke General and Credit Valley hospitals, where the study was conducted. Between January 1999 and February 2000, patients presenting to the ED with sore throat who were older than 3 years and not already receiving antibiotics were enrolled in the study when 1 of 6 participating physicians was on duty and had the time to enter the patient in the study (convenience sample). Informed consent was obtained prior to enrollment.
Patients were examined and assessed by means of a standardized encounter form listing the factors constituting the clinical score approach: patient's age, as well as presence of cough, fever, tender anterior cervical nodes, and tonsil- lar swelling or exudate. The physician also recorded a clinical impression as to whether the patient had GAS pharyngitis and indicated whether he would prescribe an antibiotic. The sore throat score for each patient was calculated after the emergency visit.
For all patients, pharyngeal swabs were taken for both culture and rapid streptococcal antigen assay. The prescription of antibiotics was withheld until the physician had received the result of the rapid test. On occasion, a nurse who had been instructed in the test procedure through demonstration and written materials performed the rapid test.
Culture specimens were plated on 5% sheep blood agar plates and incubated anaerobically for 48 hours. Group A Streptococcus was identified by means of standard techniques. 9 The rapid assay was performed with the Abbott Testpack+Plus (Abbott Laboratories Ltd., Mississauga, Ont.) according to the manufacturer's instructions. The method consists of placing a throat swab into a reagent tube, adding 3 reagents in turn and pouring the mixture onto a reaction disc; a plus symbol (+) appears within 10 minutes if the result is positive.
Data analysis was performed with Microsoft Excel and Stata programs. The sensitivity and specificity of the rapid test and the sore throat score were determined and 95% confidence intervals (CIs) were compared. A positive culture result was the gold standard indicating infection. To determine the antibiotic prescribing rates had the score approach been used, previously published management recommendations were used. 6 Patients with a score of -1, 0 or 1 were classed as not requiring culture or antibiotic; those with a score of 2 or 3 were considered to require throat culture, and those with a score of 4 or 5 were considered to require an antibiotic without culture. Antibiotic use, unnecessary prescriptions and use of throat culture were also determined and compared for the 3 approaches: 1) making a decision on the basis of the rapid strep antigen test result, 2) following the recommendations of the score approach, and 3) substituting rapid testing for throat culture for patients with a sore throat score of 2 or 3. The sensitivity and specificity and the proportion of antibiotic prescriptions and throat cultures under each approach were compared by means of a chi-square test or the Fisher's exact test where n was less than 5.
Results
A total of 130 subjects were enrolled in this study. Incomplete data for 4 of the subjects resulted in their exclusion from the analysis. The majority of the encounters (83.3%) occurred in one ED, where most of the patients in the study were evaluated by one of the investigators (P.R. these, 18 (39%) were prescriptions for patients with negative throat culture results. One (3%) of the 30 patients with a sore throat score of less than 2 had a positive throat culture result, whereas 16 (43%) of the 37 patients with a score of more than 3 had a positive culture result. Table 2 outlines the accuracy of each approach in identifying cases of culture-proven GAS. If physicians had treated all patients on the basis of the rapid test results alone, then 24 of the 32 culture-proven cases would have been treated (sensitivity 75%, 95% CI 56.6%-88.5%). The false-positive rate for the rapid test was low, with a specificity of 99% (95% CI 94.2%-99.9%). The sore throat score recommends throat culture for patients with a score of 2 or 3 and treatment or culture for patients with a score of 4 or more. Thus, all patients with a positive culture result and a score of 2 or more would have been identified, for a sensitivity of 97% (95% CI 83.8%-99.9%, p = 0.03 compared with the rapid test; Fisher's exact test) and a specificity of 78% (95% CI 67.9%-85.6%, p < 0.001 compared with the rapid test). The combined strategy, substituting a rapid test for throat culture in patients with a score of 2 or 3 would have missed an additional 3 patients with a positive throat culture result, for an overall sensitivity of 88% (28/32). This was not statistically different from the sensitivity of the rapid test or the score approach. The specificity of the combined strategy was the same as for the score approach (78%). The impact of each of these approaches on throat culture use, antibiotic prescriptions and unnecessary antibiotic use is shown in Table 3 . Throat culture was not assessed as a component of observed physician care because a throat swab was obtained for all patients as part of the study, and physicians were not asked if they would have normally ordered throat culture. The rapid test and combined strategy would have eliminated the need for throat cultures, whereas the score approach would have recommended throat culture for 59 (47%) of encounters. Of these, 15 results (25%) would have been positive; therefore, the score approach would require a subsequent phone call to 15 (11.9%) of the 126 patients to inform them of results and ensure appropriate treatment. This is a 53% reduction in telephone follow-up compared with a strategy involving throat culture for all patients (32 [25. 4%] positive cultures requiring telephone follow-up; p = 0.06), but still represents significantly more follow-up than with the strategy incorporating rapid testing.
Unnecessary antibiotic prescriptions would have been similar with the score approach, the combined strategy and observed physician care. Unnecessary prescriptions would have been significantly reduced with a strategy of rapid testing for all patients (94% reduction, p < 0.001).
Discussion
In this study we found that the sore throat score accurately predicted the likelihood of GAS-positive throat culture in community hospital ED patients. Infection was unlikely with a score less than 2 and occurred in 43% of patients with a score greater than 3. Previously published management recommendations to not treat the former group and to prescribe antibiotics for the latter group seem reasonable. For patients with a score of 2 or 3, the rapid test is not sufficiently sensitive to completely replace culture: a positive result with the rapid test warrants antibiotic treatment, whereas a negative result requires culture confirmation. This strategy would result in maintenance of the sensitivity for detecting GAS infection and would reduce the number of patients requiring follow-up.
Rapid testing in the ED of all patients presenting with a sore throat would result in a significantly lower sensitivity for identifying infection than with the sore throat score approach. Suboptimal sensitivity of rapid testing has been noted in other studies as well. 10 A combined strategy of using the sore throat score but incorporating a rapid test for patients with a score of 2 or 3 was suggested in a recent review of sore throat decision rules 11 and was also proposed in a family practice setting. 12 This strategy had a somewhat higher sensitivity than rapid testing of all patients but lower sensitivity than the score approach alone. An unresolved question is whether or not such differences are clinically important, considering that most patients do not seek medical care for sore throats.
In this patient group, a combined strategy not using any throat cultures would have eliminated the need for any telephone follow-up. However, for confirmation by throat culture of all negative rapid test results, 44 patients (34.9%) would still have needed throat culture. Of these, 3 results (representing 2.4% of all visits) would have been positive and would have required telephone follow-up. In contrast, 15 patients (11.9%) would have required telephone follow-up if only the score approach had been used.
There were no differences in overall antibiotic use and unnecessary antibiotic prescriptions for any of the strategies except universal rapid testing. Unnecessary antibiotic use would be substantially reduced with rapid testing of all patients. However, a substantial number of cases of GAS infection would be missed. If rapid testing were performed for all patients with a score of 2 or more, in an effort to reduce unnecessary antibiotic use, the sensitivity of the combined approach would be reduced further (to 75%).
Rapid tests have been available for almost 2 decades and have undergone considerable modification over that period. 13 All rapid assay kits include reagents to extract streptococcal antigens from the swab. Most assays are based on antibody recognition of specific group carbohydrate antigens of GAS. The major differences between the tests are the techniques for visualizing the bound GAS antigens.
The earliest tests were based on latex agglutination. After extraction of GAS antigen from a throat swab, the solution was mixed on a slide with latex reagent containing bound GAS antibodies. After gentle rocking, the presence of the antigen would cause a grainy precipitate to form, demonstrating the presence of GAS. Sensitivity was about 76%. 10, [14] [15] [16] [17] The next generation of rapid assays were enzyme-linked immunosorbent assays (ELISAs). In ELISA one GAS antibody, called the "capture" antibody, is attached to a solid plate. A second "detection" antibody is conjugated to a reporter label. When extracted GAS antigen is added to the plate, it becomes sandwiched between the 2 antibodies, which allows it to be visualized. Most trials have found that the variants of this technique have a sensitivity of about 80%. 18, 19 In this study we used an ELISA assay.
Optical immunoassays (OIAs) were developed in the early 1990s and are thought to be more sensitive than older assay techniques. 20 OIA systems use polyclonal anti-GAS antibody attached to thin silicon wafers. 21 Light reflected from the surface of the wafers is normally golden. GAS antigen binds to the wafer, and when a second solution is added, containing a substrate that selectively binds to the antigen-antibody complex, the changed thickness of the film causes the colour of the reflected light to change. In clinical trials, this technique has had a sensitivity of about 90%. [22] [23] [24] [25] [26] Some studies have found that OIAs have higher sensitivity than traditional throat culture. 23, 27 The early rapid assays were not thought to be sufficiently sensitive to replace throat culture, a belief reflected in current pharyngitis guidelines. The American Heart Asso- The sore throat score approach
Step 1. Determine the sore throat score:
Criteria Points Total score is determined by summing the points for the criteria.
Step 2. Suggested management strategy based on total sore throat score: ciation (AHA), the Canadian Paediatric Society and the Infectious Disease Society of America all recommend that a positive result on rapid assay is sufficient evidence to treat pharyngitis with antibiotics. 2, 3, 28 However, they all recommend that a negative result be confirmed with throat culture. Most of these guidelines were published before OIAs had been tested. The AHA recognized these newer tests, yet felt that further evaluation was needed before recommendations for their clinical use could be made.
The relatively small number of cases of sore throat in the present study dictates caution in interpreting the results. In addition, one physician did most of the assessments, and all physicians were aware of the rapid test results before they made any decision about prescribing antibiotics. It would be prudent to replicate this study in another ED with larger numbers of patients. In addition, the prevalence of positive throat culture results in our study (25.4%) was somewhat higher than in the original study in an ED by Centor and associates 8 (17%). This difference suggests that the current study population may have been a somewhat selected group of patients with sore throat. The relatively high sensitivity of the score approach in this study was similar to that observed for children. 29, 30 Almost half of the patients presenting with sore throat in this study were children.
The use of the sore throat score approach in the ED is valid and would result in 50% fewer telephone follow-up calls for positive results than would be the case if throat culture was performed for all patients. Rapid testing of all patients would eliminate the need for follow-up but would also result in a substantial number of cases of GAS infection being missed. A combined strategy of rapid testing for patients with a sore throat who have a score of 2 or 3 would further reduce the need for telephone follow-up, even if negative results of the rapid test were confirmed by culture. Further research using newer rapid tests may confirm that culture is unnecessary for patients with negative results.
